Blog
RSS FeedPosted by Michael Wonder on 02 Dec 2019
Top 10 drugs 2018–19
2 December 2019 - Rosuvastatin calcium (Crestor) was the top PBS/RPBS drug by prescription counts. ...
Posted by Michael Wonder on 21 Nov 2019
Pricing tactics slow uptake of generic drugs by Medicare plans
21 November 2019 - Study finds new copycat medicines take years to win coverage. ...
Posted by Michael Wonder on 18 Nov 2019
Biosimilars make progress in the Canadian market, but stakeholders see more work ahead
18 November 2019 - While much attention over the past few weeks has been on the US biosimilars market, with its ...
Posted by Michael Wonder on 13 Nov 2019
Epilepsy NZ calls for halt to drug switch following deaths of three people
13 November 2019 - Epilepsy New Zealand is urging authorities to immediately halt a drug switch following the death of ...
Posted by Michael Wonder on 10 Oct 2019
Biosimilars in the UK: where are we now and where does the NHS want to go?
9 October 2019 - The UK health service has well over a decade’s experience of dealing with biosimilars, but the ...
Posted by Michael Wonder on 09 Oct 2019
Prescription opioid dispensing in Australian children and adolescents: a national population-based study
8 October 2019 - There are few population-based studies of paediatric opioid use. ...
Posted by Michael Wonder on 23 Sep 2019
Two more bills aiming to boost biosimilars introduced in Congress
23 September 2019 - Two biosimilar bills, both with bipartisan sponsors, were unveiled last week and aim to boost uptake in ...
Posted by Michael Wonder on 18 Sep 2019
Xanax still being overprescribed despite policy changes
19 September 2019 - Patients are still being prescribed hundreds of Xanax tablets a year despite a cut in government ...
Posted by Michael Wonder on 12 Sep 2019
Draft Pelosi plan targets drugs lacking biosimilar or generic option
12 September 2019 - While chances of her leaked plan to force lower drug prices in the United States getting through ...
Posted by Michael Wonder on 11 Sep 2019
We need to make biosimilars easier to get
11 September 2019 - If potential biosimilar manufacturers can’t get their product to market, they won’t proceed with development. ...
Posted by Michael Wonder on 11 Sep 2019
Anti-depressant medicine brand switch: 'They've been used as guinea pigs'
11 September 2019 - Emotions ran high at the Health Select Committee today, with MPs grilling Medsafe and the Ministry ...
Posted by Michael Wonder on 10 Sep 2019
Drug formulary managers' use of step therapy can lead to sub-optimal outcomes
9 September 2019 - Over the past two decades the use of step therapy or edits by health insurers has ...
Posted by Michael Wonder on 10 Sep 2019
Erosion of physician and patient treatment choice continues - Alliance for Safe Biologic Medicines raises concerns for patients as British Columbia expands biologics forced switching policy
10 September 2019 - On 5 September, the Government of British Columbia announced that it would be forcibly switching 1,700 patients ...
Posted by Michael Wonder on 08 Sep 2019
'Barriers in place': access to asthma medication key to reducing deaths
8 September 2019 - High school teacher Gabriel Wenman admits she was once terrible at taking her asthma medication. ...
Posted by Michael Wonder on 02 Sep 2019
Biosimilars Forum’s public letter in response to anti-biosimilars Op-Ed
29 August 2019 - Government Should Not “Throw In the Towel on Biosimilars,” They Should Act Now to Unlock Billions ...